NASDAQ:PRME
Prime Medicine, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.primemedicine.comipo date
Oct 20, 2022
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the de...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus